BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21436170)

  • 1. The changing epidemiology of HIV-infected patients in the intensive care unit.
    Akgün KM; Pisani M; Crothers K
    J Intensive Care Med; 2011; 26(3):151-64. PubMed ID: 21436170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
    Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
    HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of HIV-infected patients admitted to the intensive care unit in the era of highly active antiretroviral therapy.
    Adlakha A; Pavlou M; Walker DA; Copas AJ; Dufty N; Batson S; Edwards SG; Singer M; Miller RF
    Int J STD AIDS; 2011 Sep; 22(9):498-504. PubMed ID: 21890545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Khouli H; Afrasiabi A; Shibli M; Hajal R; Barrett CR; Homel P
    J Intensive Care Med; 2005; 20(6):327-33. PubMed ID: 16280405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical care of HIV infected patients in the highly active antiretroviral therapy era.
    Corona A; Raimondi F
    Minerva Anestesiol; 2007 Dec; 73(12):635-45. PubMed ID: 18046294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy.
    Dickson SJ; Batson S; Copas AJ; Edwards SG; Singer M; Miller RF
    Thorax; 2007 Nov; 62(11):964-8. PubMed ID: 17517829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy.
    Morris A; Creasman J; Turner J; Luce JM; Wachter RM; Huang L
    Am J Respir Crit Care Med; 2002 Aug; 166(3):262-7. PubMed ID: 12153955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical Care in Human Immunodeficiency Virus-Infected Patients.
    Akgün KM; Miller RF
    Semin Respir Crit Care Med; 2016 Apr; 37(2):303-17. PubMed ID: 26974306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening complications of HIV infection.
    Davaro RE; Thirumalai A
    J Intensive Care Med; 2007; 22(2):73-81. PubMed ID: 17456727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early antiretroviral therapy for HIV-infected patients admitted to an intensive care unit (EARTH-ICU): A randomized clinical trial.
    Boniatti MM; Pellegrini JAS; Marques LS; John JF; Marin LG; Maito LRDM; Lisboa TC; Damiani LP; Falci DR
    PLoS One; 2020; 15(9):e0239452. PubMed ID: 32956419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of Pneumocystis carinii and community-acquired pneumonia with tobacco use in HIV disease.
    Miguez-Burbano MJ; Ashkin D; Rodriguez A; Duncan R; Pitchenik A; Quintero N; Flores M; Shor-Posner G
    Int J Infect Dis; 2005 Jul; 9(4):208-17. PubMed ID: 15916913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of comorbid [corrected] conditions on critical illness.
    Esper AM; Martin GS
    Crit Care Med; 2011 Dec; 39(12):2728-35. PubMed ID: 22094497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.
    Vincent B; Timsit JF; Auburtin M; Schortgen F; Bouadma L; Wolff M; Regnier B
    Intensive Care Med; 2004 May; 30(5):859-66. PubMed ID: 14767592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia in HIV-infected children: a global perspective.
    Gray DM; Zar HJ
    Curr Opin Pulm Med; 2010 May; 16(3):208-16. PubMed ID: 20375782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antiretroviral therapy in critically ill patients: a French national study].
    Dinh A; Salomon J; Vuagnat A; De Truchis P; Maury E; Bernard L
    Med Mal Infect; 2007 Dec; 37(12):809-15. PubMed ID: 17628372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality.
    Wyatt CM; Arons RR; Klotman PE; Klotman ME
    AIDS; 2006 Feb; 20(4):561-5. PubMed ID: 16470120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients.
    Nuesch R; Geigy N; Schaedler E; Battegay M
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):684-7. PubMed ID: 12373504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.